CCTA-1523
CCTA-1523 is a potent, selective, reversible and orally active ABCG2 inhibitor. CCTA-1523 shows cytotoxicity. CCTA-1523 shows anticancer activity.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1616271-41-0
- Formule: C16H15Cl2NO3
- Masse moléculaire:340.20
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
CCTA-1523 (0-1000 µM; 72 h) shows cytotoxicity for H460, H460/MX20, HEK293/pcDNA3.1, HEK/R482, HEK/R482G and HEK/R482T cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:NCR nude mice (H460/MX20 xenografts)[1]
-
Dosage:75 mg/kg (DOX ;1.8 mg/kg, i.p., q3d X 6)
-
Administration:P.o.;q3d x 6
-
Result:Significantly inhibited the growth of H460/MX20 tumor xenografts when combined with doxorubicin compared to the vehicle control group.
Chemical Information
-
CAS No. 1616271-41-0
-
Masse moléculaire 340.20
-
Formule C16H15Cl2NO3
-
SMILES
O=C(C(Cl)Cl)NC1=CC(C2=CC=C(C(OC)=C2)OC)=CC=C1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)